David G. Maggs

机构：Metcalf Foundation

发表论文 105 篇 · 总被引 7082 次 · h-index 41

代表论文

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years (2007 · Current Medical Research and Opinion · 被引 702)
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years (2008 · Current Medical Research and Opinion · 被引 228)
Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add‐on therapy in subjects with new‐onset diabetes. Results from the E fficacy and D urability of I nitial C ombination T herapy for T ype 2 D iabetes ( EDICT ): a randomized trial (2014 · Diabetes Obesity and Metabolism · 被引 206)
GLP‐1 based therapies: differential effects on fasting and postprandial glucose (2012 · Diabetes Obesity and Metabolism · 被引 113)
Effects of Exenatide Plus Rosiglitazone on β-Cell Function and Insulin Sensitivity in Subjects With Type 2 Diabetes on Metformin (2010 · Diabetes Care · 被引 103)
Exploring the Substitution of Exenatide for Insulin in Patients With Type 2 Diabetes Treated With Insulin in Combination With Oral Antidiabetes Agents (2007 · Diabetes Care · 被引 96)